Abstract
Migraine is a complex debilitating neurovascular disease affecting approximately 15% of the Western populations. Familial clustering, twin studies and segregation analyses suggest that migraine has a significant genetic component, but the number of genes involved remains unclear. The progress in migraine genetics has recently jumped ahead with the identification of genes responsible for Familiar Hemiplegic Migraine (FHM), a rare subtype of migraine with aura showing autosomal dominant mode of inheritance. Nevertheless, the knowledge about common types of migraine has been particularly rewarding and recently, seven loci with significant linkage to migraine with or without aura have been identified on 1q31, 4q24, 6p12.2-21.1, 11q24, 14q21.2-q22.3, 15q11-q13 and Xq24-28, suggesting the presence of migraine susceptibility genes in these regions. Identification of genes predisposing to the more common and genetically complex forms of migraine has been complicated by clinical and genetic heterogeneity of the disease. The major challenge in the coming years facing biomedical research of migraine is the identification of disease-susceptibility genes and the understanding of how migraine risk can be influenced by the interaction of these variants with each other and with specific environmental factors in order to provide individuals with clinically-useful diagnostic, prognostic and therapeutic information. This paper briefly summarizes the previous knowledge and highlights some recent developments in the complex genetic nature of migraine.
Keywords: Familial hemiplegic migraine, migraine with aura, migraine without aura
Current Genomics
Title: The Molecular Genetics of Migraine: Toward the Identification of Responsible Genes
Volume: 7 Issue: 1
Author(s): Fernando Gianfrancesco and Teresa Esposito
Affiliation:
Keywords: Familial hemiplegic migraine, migraine with aura, migraine without aura
Abstract: Migraine is a complex debilitating neurovascular disease affecting approximately 15% of the Western populations. Familial clustering, twin studies and segregation analyses suggest that migraine has a significant genetic component, but the number of genes involved remains unclear. The progress in migraine genetics has recently jumped ahead with the identification of genes responsible for Familiar Hemiplegic Migraine (FHM), a rare subtype of migraine with aura showing autosomal dominant mode of inheritance. Nevertheless, the knowledge about common types of migraine has been particularly rewarding and recently, seven loci with significant linkage to migraine with or without aura have been identified on 1q31, 4q24, 6p12.2-21.1, 11q24, 14q21.2-q22.3, 15q11-q13 and Xq24-28, suggesting the presence of migraine susceptibility genes in these regions. Identification of genes predisposing to the more common and genetically complex forms of migraine has been complicated by clinical and genetic heterogeneity of the disease. The major challenge in the coming years facing biomedical research of migraine is the identification of disease-susceptibility genes and the understanding of how migraine risk can be influenced by the interaction of these variants with each other and with specific environmental factors in order to provide individuals with clinically-useful diagnostic, prognostic and therapeutic information. This paper briefly summarizes the previous knowledge and highlights some recent developments in the complex genetic nature of migraine.
Export Options
About this article
Cite this article as:
Gianfrancesco Fernando and Esposito Teresa, The Molecular Genetics of Migraine: Toward the Identification of Responsible Genes, Current Genomics 2006; 7 (1) . https://dx.doi.org/10.2174/1389202910607010001
DOI https://dx.doi.org/10.2174/1389202910607010001 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Myocardial Contrast Echocardiography: Role in Clinical Cardiology
Current Vascular Pharmacology Nanostructures for Drug Delivery to the Brain
Current Medicinal Chemistry Is Atorvastatin Superior to Other Statins? Analysis of the Clinical Trials with Atorvastatin Having Cardiovascular Endpoints
Reviews on Recent Clinical Trials Role of Sensory Neurons in Restitution and Healing of Gastric Ulcers
Current Pharmaceutical Design Metabolic Syndrome, Mild Cognitive Impairment and Dementia
Current Alzheimer Research Fabrication and Characterization of Ocular Phase Transition Systems for Blepharitis: A Novel Approach
Drug Delivery Letters Diabetes Mellitus and Vascular Endothelial Dysfunction: Current Perspectives
Current Vascular Pharmacology Microdialysis in Neurointensive Care
Current Pharmaceutical Design Lipoxins, The Novel Mediators of Gastroprotection and Gastric Adaptation to Ulcerogenic action of Aspirin
Current Pharmaceutical Design Anti-platelet Drug-loaded Targeted Technologies for the Effective Treatment of Atherothrombosis
Current Drug Targets Nimodipine Reappraised: An Old Drug With a Future
Current Neuropharmacology Microcirculation of the Diabetic Foot
Current Pharmaceutical Design Mechanisms of Esophageal Protection, Gastroprotection and Ulcer Healing by Melatonin. Implications for the Therapeutic use of Melatonin in Gastroesophageal Reflux Disease (GERD) and Peptic Ulcer Disease
Current Pharmaceutical Design Exercise Rehabilitation for the Patient with Intermittent Claudication: A highly Effective yet Underutilized Treatment
Current Drug Targets - Cardiovascular & Hematological Disorders Gut-Brain Axis in Gastric Mucosal Damage and Protection
Current Neuropharmacology Transcranial Doppler Ultrasonography: Current Status
Current Medical Imaging Modeling of LIM-Kinase 2 Inhibitory Activity of Pyrrolopyrimidine Analogues: Useful in Treatment of Ocular Hypertension and Glaucoma
Medicinal Chemistry Clinical Implications of COX-1 and / or COX-2 Inhibition for the Distal Gastrointestinal Tract
Current Pharmaceutical Design Imaging Subclinical Atherosclerosis: Where Do We Stand?
Current Cardiology Reviews Neuroinflammation and Immunity: A New Pharmacological Target in Depression
CNS & Neurological Disorders - Drug Targets